85 related articles for article (PubMed ID: 18514346)
1. Mutations at nucleotides 573 and 579 within 5'-untranslated region augment the virulence of coxsackievirus B1.
Zhong Z; Li X; Zhao W; Tong L; Liu J; Wu S; Lin L; Zhang Z; Tian Y; Zhang F
Virus Res; 2008 Aug; 135(2):255-9. PubMed ID: 18514346
[TBL] [Abstract][Full Text] [Related]
2. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
3. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants for virulence in coxsackievirus B1 infection.
Rinehart JE; Gómez RM; Roos RP
J Virol; 1997 May; 71(5):3986-91. PubMed ID: 9094675
[TBL] [Abstract][Full Text] [Related]
5. Role of GNRA motif mutations within stem-loop V of internal ribosome entry segment in coxsackievirus B3 molecular attenuation.
M'hadheb-Gharbi MB; El Hiar R; Paulous S; Jaïdane H; Aouni M; Kean KM; Gharbi J
J Mol Microbiol Biotechnol; 2008; 14(4):147-56. PubMed ID: 17693702
[TBL] [Abstract][Full Text] [Related]
6. Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1.
Sandager MM; Nugent JL; Schulz WL; Messner RP; Tam PE
Virology; 2008 Mar; 372(1):35-47. PubMed ID: 18029287
[TBL] [Abstract][Full Text] [Related]
7. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
[TBL] [Abstract][Full Text] [Related]
8. Functional formation of domain V of the poliovirus noncoding region: significance of unpaired bases.
Rowe A; Burlison J; Macadam AJ; Minor PD
Virology; 2001 Oct; 289(1):45-53. PubMed ID: 11601916
[TBL] [Abstract][Full Text] [Related]
9. [Antisense oligonucleotide inhibition of coxsackievirus B3 gene expression in HeLa cells and dose-response experiments].
Liu ZW; Sun HM; Xiao ZH; Qiu N; Zhang T; Zhao JM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):62-5. PubMed ID: 15340530
[TBL] [Abstract][Full Text] [Related]
10. The structure and function of a cis-acting element located upstream of the IRES that influences Coxsackievirus B3 RNA translation.
Bhattacharyya S; Verma B; Pandey G; Das S
Virology; 2008 Aug; 377(2):345-54. PubMed ID: 18533219
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of disease in coxsackievirus B1 murine infection.
Cifuente JO; Ferrer MF; Jaquenod de Giusti C; Song WC; Romanowski V; Hafenstein SL; Gómez RM
J Med Virol; 2011 Sep; 83(9):1571-81. PubMed ID: 21739448
[TBL] [Abstract][Full Text] [Related]
12. Mutations that alter a repeated ACCA element located at the 5' end of the Potato virus X genome affect RNA accumulation.
Park MR; Kwon SJ; Choi HS; Hemenway CL; Kim KH
Virology; 2008 Aug; 378(1):133-41. PubMed ID: 18589472
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B4: in vitro genetic markers and virulence.
Jimes S; Jamison RM
Arch Virol; 1983; 77(1):1-11. PubMed ID: 6312933
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus B3 infection and its mutation in Keshan disease.
Ren LQ; Li XJ; Li GS; Zhao ZT; Sun B; Sun F
World J Gastroenterol; 2004 Nov; 10(22):3299-302. PubMed ID: 15484304
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses.
Tam PE; Fontana DR; Messner RP
J Lab Clin Med; 2003 Sep; 142(3):196-204. PubMed ID: 14532908
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic mutations in the 5' untranslated region of BCS1L mRNA in mitochondrial complex III deficiency.
Gil-Borlado MC; González-Hoyuela M; Blázquez A; García-Silva MT; Gabaldón T; Manzanares J; Vara J; Martín MA; Seneca S; Arenas J; Ugalde C
Mitochondrion; 2009 Sep; 9(5):299-305. PubMed ID: 19389488
[TBL] [Abstract][Full Text] [Related]
17. Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.
Tam PE; Weber-Sanders ML; Messner RP
J Virol; 2003 Nov; 77(21):11849-54. PubMed ID: 14557670
[TBL] [Abstract][Full Text] [Related]
18. Uncommon cytidine-homopolymer dimorphism in 5'-UTR of the human otoferlin gene.
Mirghomizadeh F; Pfister M; Blin N; Pusch CM
Int J Mol Med; 2003 Jan; 11(1):63-4. PubMed ID: 12469219
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes.
Ortner B; Huang CW; Schmid D; Mutz I; Wewalka G; Allerberger F; Yang JY; Huemer HP
J Med Virol; 2009 Feb; 81(2):317-24. PubMed ID: 19107980
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the leader sequence to homologous viral interference among Sendai virus strains.
Shimazu Y; Takao SI; Irie T; Kiyotani K; Yoshida T; Sakaguchi T
Virology; 2008 Mar; 372(1):64-71. PubMed ID: 18035388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
